Şizofreni ve Depresyonda <Single Photon Emission Computed Tomography» (Spect) ve «Posttron Emission Tomography»

Year 1992, Volume: 45 Issue: 3 , 529 - 540 , 30.09.1992

Binnur Karayalçın

https://izlik.org/JA63YT65XX

Abstract

Psikiyatrik hastalıkların değerlendirilmesinde, PET ile yapılan
önemli katkılardan sonra, serebral SPECT çalışmaları da çok umut
verici görünmektedir. Özellikle son yıllarda, SPECT teknolojisindeki
gelişmelere ve yeni radyo-farmasötiklerin bulunmasına paralel olarak
bu konuda yapılan çalışmalar hızla artmaktadır. Hernekadar elde
edilen sonuçlar henüz mental hastalıkların tanısında ve sınıflandırı!-
masında patognomonik olmasada, özellikle şizofreninin bazı formları
ile depresyonun değerlendirilmesine önemli katkıları olmuştur. Bir diger önemli husus, hastaya uygun tedavinin seçiminde ve tedaviye alınan yanıtın değerlendirilmesinde, halen kabul edilmiş olan klinik prametreler yanında önemli objektif kriter olacağıdır. Ayrıca kullanılan radyofarmasötiklerin geliştirilmesi, özellikle reseptör görüntülenmesine yönelik çalışmalar, bazı psikiyatrik hastalıkların etiopatogenezini aydınlatmada yardımcı olacaktır.

Keywords

Şizofreni , Depresyon , SPECT , PET.

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

«SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY» (SPECT) AND «POSTTRON EMISSION TOMOGRAPHY» IN SCHIZOPHRENIA AND DEPRESSION

https://izlik.org/JA63YT65XX

Abstract

After major contribution of PET studies to the assessment of schizophrenia and affective disorders, SPECT imaging also seems to be
promising. Especially recent developments in SPECT technology and
new radiopharmaceuticals have contributed significant advanceş in
the evaluation of mental disorders. Although the results are not yet
patognomonic for diagnosing and subtyping mental disorders, some
improvements were obtained in some forms of schizophrenia and
depression. In addition, SPECT receptor site imaging will be guite
useful to elucidate the underilying mechanisms responsible for some
phychiatric disease.

Keywords

Schizophrenia , Depression , SPECT , PET.

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Andreasen NC Olsen S : Negative versus positive schizophrenia : Definition and validation. Arch Gen Psychiatry 39 ; 789-704, 1982.
• 2. -Andreasen NC ; Positive versus negalive sehizopbrenia : A critical review, Schizophr Bull 11 : 380-389, 1985.
• 3. Ariel RN Gaolder JC et al : Regional cerebral blood flow sehizophrenia. Arch Gen Psychiatry 40 : 258-263, 1988.
• 4, Bajc M Medved Vetal: Cerebral perfusion inhomogenities in schizophrenia demonstrated with single photon emission computed tomograplıy and Te-89m HMPAO. Acta Psychiatr Scand 80 ; 427-433, 1988.
• 5. Baxter LR Jr Phelps ME et al ; Ceröbral mnetabolic rates for glucose in mood disorders. Studies with positron emission tomography and İluorodeoxyglucose F-18. Arch Gen Psychiatry 42 : 441-447, 1985.
• 6. Baxter LR Jr Schwartz JM Phelps ME et al: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243-250, 1980.
• 7. Crawley JCW, Smith T et al: Dopamine receptors displayed in living human brain with Br-77-p-bromospiperone, Lancet 2: 975, 1983.
• 8. Devous MD Bonte FJ Initial evaluation of cerebral blood Imaging with high- resolution, highsensitivity three-headed SPECT system (PRISM). J Nucl Med 20: 012, 1888.
• 9. Devous MD Sr Paulman RG et al: SPECT regional cerebral blood flow measure- ments correlate with neuropsychological dsyfunction in schizophrenic patients. J Nucl Med 28: 698-699, 1987.
• 10. Eichling JO Ter-Pogossian MM: Methodological shortcomings of the Xe-133 inhalation technique of measuring rCBF. Acta Neurol Scand 58: 464-465, (suppl 64) 1977.
• 11. English RJ Holman BL: Current status of cerebral perfusion radiopharmace uticals. J Nucl Med Tech 15: 30, 1987.
• 12. Farkas T Wolf AP Jaegar Jet al: Regional brain glucose metabolism in chro- nic schizophrenia emission computed tomography measurements with 11-C- glucose. Arch Gen Psychiatry 41: 263-300, 1964.
• 13. Franzen G Ingvar DH: Abnormal distribution of cerebral activity in chronic schizophrenics. J Psychiatr Res 12: 199-214, 1975.
• 14. Gibson RE Schneidau TA Cohen VI et al: In vitro and in vivo characteristics of (lodine-125) 3-(R)-quinuclindinyl S (4)-iodo benzilate. J Nucl Med 30 1079- 1087, 1980.
• 15. Gur RE Resnick SM et al: Regional brain function in schizophrenia. A positron emission tomography study. Arch Gen Psychiatry 44: 119-125, 1987.
• 16. Hawton K Shepstone B Soper Net al Single photon emission computerised tomography (SPECT) in schizophrenia. Br J Psychiatry 156: 425-27, 1990.
• 17. Kuhl DE Barrio JR Huang SC et al: Quantifying local cerebral blood flow by N-Isopropyl p-(123)-iodoamphetamine (IMP) tomography. J Nucl Med 23: 106- 203, 1988.
• T 18. Kung HV Alavi A Billings J et al: (I-123) IBZP: a potential CNS D-1 dopaminə receptor imaging agent Invivo biodistribution in monkey. J Nucl Med 20: 758, 1968.
• 19. Kung MP Murphy RA Billings Jet al: (I-123) IHZP a potential CNS D-2 do- pamine receptor imaging agent. J Nucl Med 30: 762, 1969,
• 20. Kurachi M Kobayashi Ket al: Regional cerebral blood flow in schizophrenic disorders. Eur Neurol 24 176-181, 1985.
• 21. Lassen NA Blasberg RG: Technetium-99m-d, 1-HM-PAO, the development of a new class of TC-90m labeled tracers. An overview. J Cereb Blood Flow Metab 8:1-3, (suppl 1) 1988.
• 22. Lassen NA Henriksen L Holm Set al: Cerebral blood flow tomography: Xe-133 compared with Isopropyl-amphetamine-iodine 123: A concise communication. J Nucl Med 24: 17-21, 1983.
• 33. Lassen NA Sveinsdottir E et al: A fast moving single photon emission tomog- raphy for regional cerebral blood flow studies in man. J Comput Assist Tomogr 2: 681-062, 1978.
• 24. Lear J: Quantitative local cerebral blood flow measurements with Tc-99m HMPAO: evaluation using multiple radionuclide digital quantitative autoradi- ography. J Nucl Med 29: 1387-1392, 1988,
• 25. Mathew RJ Meyer JS et al: Cerebral blood flow in depression. Am J Psychiatry 137: 1440-1450, 1880.
• 26. Matsuda H Gyobu Tet al: Increased accumulation of N-Isopropyl (1-123) p-jodo- amphetamine in the left auditory area in schizophrenic patients with auditory hallucinations. Clin Nucl Med 13: 53-55, 1988,
• 27. Maurer AH: Nuclear Medicine: SPECT comparisons to PET. Radiol Clin North Am 26: 1059-1074, 1988.
• 28. O'Connell RA Van Heertum RL et al: Single photon emission computed tomog- raphy (SPECT) with (I-123) IMP in the differantial diagnosis of psychiatric di- sorders. J Neuropsychiatry 1: 145-153, 1989.
• 29. Phelps ME Mazziotta JC et al: Positron emission tomographic study of affec- tive disorders: Problems and strategies. Ann Neurol 15: S 149-S 156, 1984.
• 30. Sedvall GC Farde Let al: Imaging of neurotransmitter receptors in the living brain. Arch Gen Psychiatry 43: 995-1005, 1988.
• 31. Shepstone BJ Cerebral scintigraphy the phoenix rises again. Postgrad Med J 64: 4-17, 1988.
• 32. Simon TR Devous MO et al: Regional cerebral function and blood flow com- plementary single photon emission computed tomography of the brain using Xe-133 and (1-123) todoamphetamine. Int J Rad Appl Instrum (B) 6: 295-300, 1969.
• 33. Widen L Bergstrom M Blomqvist Get al: Glucose metabolism in patients with schizophrenia: emission computed tomopraghy measurements with 11-C-gluco- se. J Cereb Blood Flow Metab (suppl 1): S 455-8 456, 1981.
• 34. Wilhelm KR Schroder J et al: Preliminary results of Tc-99m HMPAO-SPECT studies in endogenous psychoses. Nuklearmedizin 28: 88-91, 1989.
• 35. Winchell HS Host WD Braun Let al: N-Isopropyl (I-123) p-iodoamphetamine: Single pass brain uptake and washout; Binding for brain synaptosomes and isolation in dog and monkey brain. J Nucl Med 21: 047-052, 1980.
• 36. Wolkin A Jaegar J Brodie JD et al: Persistence of cerebral metabolic abnor- malities in chronic schizophrenia as determined by positron emission tomog- raphy. Am J Psychiatry 142: 504-571, 1985.
• 37. Wong OF Wagner HN et al: Positron emission tomography reveals D2 dopa- mine receptors in drug-naive schizophrenics. Science 234: 1558-1563, 1966.
• 38. Yonekura Y Nishizawa S Mukai T et al: SPECT with Tc-99m HMPAO compared with regional cerebral blood flow measured by PET effects of linearization, J Cereb Blood Flow Metab 8: 82-89, (suppl 1) 1988.